Towards Healthcare Research & Consulting
US Drug Testing Market
Updated Date: 16 June 2026   |   Report Code: 6951

US Drug Testing Market Size, Growth Trends and Forecast 2035

According to Shivani Zoting, who specializes in healthcare market diagnostics and med-tech industry analysis, with 5+ years of experience in market research and medical production research, laboratory tools, and healthcare devices indicate significant growth opportunities in the U.S. drug testing market. The market is projected to expand from USD 2.77 billion in 2026 to USD 4.65 billion by 2035, registering a CAGR of 5.9% during the forecast period. Her analysis highlights the growing demand for drug testing, increasing productivity and performance, and the increasing demand for medical diagnosis and treatment. The studies highlight that drug testing programs support employers in identifying and addressing substance use disorders in their employees, deterring strong drug users, while underscoring Canada and Mexico as significant regional growth hubs. The studies also identify the competitive strategies of key industry participants, involving Labcorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, and OraSure Technologies, shaping the future of fertility diagnostic and research solutions in the U.S. 

Last Updated : 16 June 2026 Category: Diagnostics Insight Code: 6951 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • US Drug Testing Market Analysis, By Product Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Drug Testing Market Analysis, By Sample Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Drug Testing Market Analysis, By Drug Type
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Drug Testing Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Drug Testing Market Analysis, By Testing Setting
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • US Drug Testing Market Analysis, By Segment 3
    • Market Size, Forecast & CAGR, By Product Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Product Type
      • By Sample Type
      • By Drug Type
      • By Testing Method
      • By End User
      • By Testing Setting
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Company 1
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis

FAQ's

Answer : The U.S. drug testing market is worth USD 2.77 billion in 2026, and by 2035, it is forecasted to hit USD 4.65 billion, registering a CAGR of 5.9% over the decade.

Answer : DailyMed, National Drug Code (NDC) Directory, NLM Drug Information Portal, USP–NF, Micromedex, Clinical Pharmacology, Lexicomp.

Answer : Major companies operating in the market include Labcorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, OraSure Technologies, and Premier Biotech.

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar